ditiocarb has been researched along with Leishmania Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barral, A; Barral-Netto, M; de Oliveira, CI; Khouri, R; Novais, F; Santana, G; Van Weyenbergh, J; Vannier dos Santos, MA | 1 |
| Namazi, MR | 1 |
2 other study(ies) available for ditiocarb and Leishmania Infection
| Article | Year |
|---|---|
DETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.
Topics: Adjuvants, Immunologic; Animals; Antioxidants; Apoptosis; Cell Survival; Ditiocarb; Humans; Leishmania; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Mitochondria; Necrosis; Phagosomes | 2010 |
Potantial utility of disulfiram against leishmaniasis.
Topics: Adjuvants, Immunologic; Animals; ATP Binding Cassette Transporter, Subfamily B; Chelating Agents; Disulfiram; Ditiocarb; Drug Resistance; Glutathione; Humans; Leishmania donovani; Leishmania major; Leishmania tropica; Leishmaniasis; Nitric Oxide; Oxidative Stress | 2008 |